These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 31729681)

  • 21. Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT.
    Zhang Y; Ji G; Han S; Shao Z; Lu Z; Huo L; Zhang J; Yang R; Feng Q; Shen H; Wang H; Li X
    Cell Physiol Biochem; 2018; 50(2):612-628. PubMed ID: 30308494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
    Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
    Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma.
    Detarya M; Thaenkaew S; Seubwai W; Indramanee S; Phoomak C; Saengboonmee C; Wongkham S; Wongkham C
    Life Sci; 2021 Apr; 271():119114. PubMed ID: 33513399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
    Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
    Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor-associated macrophages.
    Ke K; Lin J; Huang N; Yan L; Liao R; Yang W
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1888. PubMed ID: 37688511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular IL-33 Attenuates Extracellular IL-33-induced Cholangiocarcinoma Cell Proliferation and Invasion
    Yangngam S; Thongchot S; Vaeteewoottacharn K; Thuwajit P; Hermoso MA; Okada S; Thuwajit C
    Anticancer Res; 2021 Oct; 41(10):4917-4928. PubMed ID: 34593439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
    Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation.
    Pan S; Hu Y; Hu M; Xu Y; Chen M; Du C; Cui J; Zheng P; Lai J; Zhang Y; Bai J; Jiang P; Zhu J; He Y; Wang J
    Int J Oncol; 2020 Jan; 56(1):101-112. PubMed ID: 31746424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the PI3K-AKT signaling pathway by SPARC contributes to the malignant phenotype of cholangiocarcinoma cells.
    Deng S; Zhang L; Li J; Jin Y; Wang J
    Tissue Cell; 2022 Jun; 76():101756. PubMed ID: 35217388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line.
    Liu R; Li X; Qiang X; Luo L; Hylemon PB; Jiang Z; Zhang L; Zhou H
    J Biol Chem; 2015 Dec; 290(52):30988-1002. PubMed ID: 26518876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression.
    Liang S; Guo H; Ma K; Li X; Wu D; Wang Y; Wang W; Zhang S; Cui Y; Liu Y; Sun L; Zhang B; Xin M; Zhang N; Zhou H; Liu Y; Wang J; Liu L
    Cancer Res; 2021 Dec; 81(23):5889-5903. PubMed ID: 34580062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.
    Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN
    Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
    Jaidee R; Kukongviriyapan V; Senggunprai L; Prawan A; Jusakul A; Laphanuwat P; Kongpetch S
    Life Sci; 2022 May; 296():120427. PubMed ID: 35218764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
    Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
    Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
    Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
    Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLAU contributes to the development of cholangiocarcinoma via activating NF-κB signaling pathway.
    Hu MD; Jia LH; Wang ML
    Cell Biol Int; 2023 Aug; 47(8):1381-1391. PubMed ID: 37067236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis.
    Jiang T; Wang C; Zhu Y; Han H
    J Gene Med; 2020 Jun; 22(6):e3162. PubMed ID: 31951299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
    Li Y; Cai Q; Li W; Feng F; Yang L
    Biochem Biophys Res Commun; 2018 Oct; 504(4):654-659. PubMed ID: 30205958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways.
    Huang GL; Zhang W; Ren HY; Shen XY; Chen QX; Shen DY
    Cancer Sci; 2015 Nov; 106(11):1515-23. PubMed ID: 26310932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.